chr14-77555304-T-C
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000216484.7(SPTLC2):āc.1172A>Gā(p.Lys391Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,614,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
ENST00000216484.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTLC2 | NM_004863.4 | c.1172A>G | p.Lys391Arg | missense_variant | 8/12 | ENST00000216484.7 | NP_004854.1 | |
SPTLC2 | XM_011537384.3 | c.1172A>G | p.Lys391Arg | missense_variant | 8/10 | XP_011535686.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTLC2 | ENST00000216484.7 | c.1172A>G | p.Lys391Arg | missense_variant | 8/12 | 1 | NM_004863.4 | ENSP00000216484 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 250876Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135620
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727238
GnomAD4 genome AF: 0.000230 AC: 35AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74470
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory and autonomic, type 1C Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at